English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the zaia usage as premium feature

ZAIA

Presents the pdf analysis as premium feature

PDF Analysis

Insights

Presents the summarisation as premium feature

Summarisation

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the access of premium content as premium feature

Premium Content

Zendy Tools

Zendy Open

Kodamaea ohmeri, previously known as Yamadazyma ohmeri and Pichia ohmeri, is ascomycetous yeast that belongs to the Saccharomycetaceae family. It is a rare clinical isolate that has recently become known to cause various human infections. Here, we report the first case of co-infection with Sars-Cov2 and Kodamaea ohmeri in Tunisian patient without underlying disease.  Methodology: We describe a patient with Covid-19 where Kodamaea ohmeri was isolated in sputum and protected tracheal samples. The identification was carried out by Vitek®2 YST ID card and confirmed by PCR sequencing. Susceptibility to antifungal was made by E-test.  Results: Kodamaea ohmeri was identified using phenotypic, biochemical, and molecular methods. The isolate was susceptible for amphotericin B, caspofungin, and intermediate sensitivity for Fluconazole.  Conclusion: Patients with severe Covid-19 are mostly colonized and co-infected with rare yeasts which are resistant to antifungals. This case incites to pay more attention to the emergence of this yeast.  Keywords: Kodamaea ohmeri; diagnosis; antifungal; molecular methods.

Coinfection with Sars-Cov2 and Kodamaea ohmeri: A case report from Tunisia